WHO enlists Globe Biotech’s COVID-19 vaccine
Published: 05:01 PM, 17 October 2020 Updated: 06:21 PM, 17 October 2020
Asif Mahmud, in-charge of research and development of Globe Biotech limited (File Photo)
The World Health Organization (WHO) has enlisted the coronavirus vaccine developed by Bangladeshi coronavirus vaccine candidate Globe Biotech.
Earlier, in a press conference, Globe Biotech said, “Their vaccine has got very promising success in the first stage of the trial in animals. Recently, they claim that the second phase of their vaccine trial in animals has met with success again. However, the news of their success has been published in the ‘Bio Archive’, a pre-print server for publishing research articles in various branches of biology.”
Researchers of Globe Biotech claimed that their vaccine is capable of preventing coronavirus infection by producing antibodies in animals.
Asif Mahmud, in-charge of research and development of Globe Biotech limited, told Daily Bangladesh on October 1 that they have named their vaccine ‘BANCOVID’, which is basically a D614G variant M-RNA based vaccine.
They have got very promising results from pre-clinical trials on rabbits and mice, he added.